CSIMarket
 


Mosaic Immunoengineering Inc   (PTSC)
Other Ticker:  
 

Mosaic Immunoengineering Inc 's Working Capital Ratio

PTSC's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2023, Working Capital Ratio fell to 0.08 below Mosaic Immunoengineering Inc average.

Within Biotechnology & Pharmaceuticals industry 169 other companies have achieved higher Working Capital Ratio than Mosaic Immunoengineering Inc in third quarter 2023. While Working Capital Ratio total ranking in the third quarter 2023 has deteriorated compared to the prior quarter from 4477 to 4501.

Explain Working Capital Ratio
How much in Current Assets PTSC´s has?
What is the value of PTSC´s Current Liabilities?


PTSC Working Capital Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Change 30.14 % 6.73 % 24.68 % 35.6 % 49.09 %
Y / Y Current Assets Change -34.05 % 65.52 % -63.21 % -3.05 % -2.86 %
Working Capital Ratio MRQ 0.08 0.1 0.04 0.08 0.15
PTSC's Total Ranking # 4501 # 4477 # 4749 # 2525 # 4931
Seq. Current Liabilities Change 6.02 % 4.73 % 7 % 9.53 % -13.05 %
Seq. Current Assets Change -22.7 % 148.78 % -43.18 % -39.65 % 94.01 %



Working Capital Ratio third quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 170
Healthcare Sector # 1021
Overall Market # 4501


Working Capital Ratio Statistics
High Average Low
80.48 26.46 0.04
(Feb 28 2015)   (Mar 31 2023)




Financial Statements
Mosaic Immunoengineering Inc 's Current Liabilities $ 4 Millions Visit PTSC's Balance sheet
Mosaic Immunoengineering Inc 's Current Assets $ 0 Millions Visit PTSC's Balance sheet
Source of PTSC's Sales Visit PTSC's Sales by Geography


Cumulative Mosaic Immunoengineering Inc 's Working Capital Ratio

PTSC's Working Capital Ratio for the trailling 12 Months

PTSC Working Capital Ratio

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities TTM Growth 30.14 % 6.73 % 24.68 % 35.6 % 49.09 %
Y / Y Current Assets TTM Growth -34.05 % 65.52 % -63.21 % -3.05 % -2.86 %
Working Capital Ratio TTM 0.08 0.09 0.08 0.11 0.12
Total Ranking TTM # 3826 # 2313 # 4131 # 4223 # 1894
Seq. Current Liabilities TTM Growth 6.02 % 4.73 % 7 % 9.53 % -13.05 %
Seq. Current Assets TTM Growth -22.7 % 148.78 % -43.18 % -39.65 % 94.01 %


On the trailing twelve months basis Due to rise in Current Liabilities in the III Quarter 2023 to $3.76 millions, cumulative Working Capital Ratio decreased to 0.08 below the Mosaic Immunoengineering Inc average Working Capital Ratio.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operating within Biotechnology & Pharmaceuticals industry 164 other companies have achieved higher Working Capital Ratio than Mosaic Immunoengineering Inc . While Working Capital Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2023 from 2313 to 3826.

Explain Working Capital Ratio
How much in Current Assets PTSC´s has?
What is the value of PTSC´s Current Liabilities?

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 165
Healthcare Sector # 1008
Within the Market # 3826


trailing twelve months Working Capital Ratio Statistics
High Average Low
49.64 10.26 0.06
(Nov 30 2017)   (Sep 30 2023)




Companies with similar Working Capital Ratio in the quarter ending Sep 30 2023, within Biotechnology & Pharmaceuticals Industry Working Capital RatioSep 30 2023 MRQ Current AssetsSep 30 2023 MRQ Current Liabilities
10x Capital Venture Acquisition Corp Iii  0.15 $ 0.825  Millions$ 5.524  Millions
Avalon Globocare Corp   0.13 $ 0.864  Millions$ 6.692  Millions
Redwoods Acquisition Corp   0.12 $ 0.204  Millions$ 1.664  Millions
Scilex Holding Company  0.11 $ 25.481  Millions$ 228.580  Millions
Agentix Corp   0.11 $ 0.334  Millions$ 3.149  Millions
Mosaic Immunoengineering Inc   0.08 $ 0.286  Millions$ 3.759  Millions
Phoenix Biotech Acquisition Corp   0.03 $ 0.141  Millions$ 4.801  Millions

Date modified: 2023-11-02T20:04:41+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com